Novartis AG
(NYSE : NVS)

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.82%150.700.7%$747.25m
BMYBristol-Myers Squibb Co. 1.06%67.431.0%$732.45m
PFEPfizer Inc. -0.40%40.350.9%$572.52m
MRKMerck & Co., Inc. -1.11%89.960.7%$567.99m
ABBVAbbVie, Inc. 0.00%88.002.3%$549.02m
LLYEli Lilly & Co. 0.96%140.921.1%$394.62m
APLSApellis Pharmaceuticals, Inc. 6.27%43.040.0%$117.42m
NVSNovartis AG 0.83%95.970.2%$110.78m
AZNAstraZeneca Plc -0.05%50.771.2%$95.39m
GSKGlaxoSmithKline Plc 1.24%48.090.2%$90.84m
KRTXKaruna Therapeutics, Inc. 4.57%109.300.0%$65.08m
NVONovo Nordisk A/S -0.26%61.150.1%$64.59m
RETAReata Pharmaceuticals, Inc. 0.71%212.933.5%$64.21m
SNYSanofi -0.62%49.900.2%$58.55m
RARXRa Pharmaceuticals, Inc. -0.23%46.860.8%$36.84m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.